Using Telemedicine to Assist in the Clinical Care of Patients With Decompensated Cirrhosis

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorNational Taiwan University Hospital

About this trial

The goal of this clinical trial is to learn if an integrated digital and telemedicine care model works to manage decompensated cirrhosis in patients. It will also learn about the impact of this model on healthcare resource consumption and patient quality of life. The main questions it aims to answer are:

1. Does this telemedicine model lower the number of cirrhosis-related hospitalizations and emergency department visits? 2. Does the model reduce medical expenses and improve disease outcomes compared to standard care?

Researchers will compare the digital telemedicine care model (utilizing the NTUH-TPC platform and wearable devices) to standard health care to see if the digital approach effectively reduces hospital admissions and medical costs.

Participants will:

1. Use the NTUH telehealth platform (NTUH-TPC) to access records and upload physiological, medical, and imaging data. 2. Wear a smart watch for remote physiological monitoring. Receive continuous remote care and proactive follow-ups from case managers.

Eligibility criteria

Qualifiers

Patients with decompensated cirrhosis and a Child score of B or C

Age: 18 years or older

Must return for a follow-up visit at least every 3 months

Disqualifiers

Patients with active malignant tumors (those with a history of malignant tumors must have been cured for at least 2 years)

Patients with an expected survival of less than one year

Trial design

Treatments tested in this trial

  • Telemedicine care

Treatment groups

120 Participants
are divided into 2 treatment groups

Sponsors and collaborators

National Taiwan University Hospital

Lead sponsor

National Science and Technology Council, Taiwan

Collaborator